MADISON, N.J., May 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on July 20, 2009, to shareholders of record on July 6, 2009.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its network of laboratories and patient service
centers, and provides interpretive consultation through its extensive medical
and scientific staff. Quest Diagnostics is a pioneer in developing innovative
new diagnostic tests and advanced healthcare information technology solutions
that help improve patient care. Additional company information is available
at: www.questdiagnostics.com.
SOURCE Quest Diagnostics
CONTACT: Laure Park (Investors), +1-973-520-2900, or Wendy Bost (Media),
+1-973-520-2800
Web Site: http://www.questdiagnostics.com
(DGX)